It is a heterogeneous disease with regard to molecular alterations, cellular composition, and clinical outcome, both between tumor subtypes and within a single tumor, which were commonly defined by gene expression profiling as four main subtypes including luminal A, luminal B, HER-2 enriched and basal-like, (2–4). This evidence concerns the gene ERBB2 and neoplasm.